{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:40:07Z","timestamp":1771922407678,"version":"3.50.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Insulin allergy, although rare in type 1 diabetes (T1DM), poses a significant clinical challenge due to the indispensable role of insulin therapy. Rapid induction of insulin tolerance is critical for affected individuals, especially in acute complications such as diabetic ketoacidosis (DKA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a case of a 50-year-old male with newly diagnosed T1DM who developed type I hypersensitivity reactions to multiple insulin analogs, manifesting as localized erythema, pruritus, and induration. After conventional management, including switching insulin preparations, proved ineffective, a rapid desensitization protocol was initiated using continuous subcutaneous insulin infusion (CSII). Preceding the pump initiation, half of the estimated basal dose of insulin glargine was administered subcutaneously. CSII with insulin aspart was then started at an extremely low initial rate, with increments every 30 minutes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The target basal infusion rate was successfully achieved within 5 hours without the use of antihistamines or corticosteroids. The procedure was well-tolerated, with no systemic or local allergic reactions. Following desensitization, the patient successfully transitioned to daily injections of glargine and pre-meal aspart insulin, with no recurrence of allergic reactions during long-term follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A CSII-based rapid desensitization protocol is a safe, effective, and efficient strategy for managing insulin allergy in T1DM, including cases with sensitivities to multiple insulin preparations. This approach is particularly suitable for patients requiring urgent insulin therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1715012","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:35:00Z","timestamp":1768545300000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Successful rapid desensitization to multiple insulin preparations in an adult with type 1 diabetes: a case report and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuwen","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Affiliated Central Hospital of Huzhou University","place":["Huzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenwen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Affiliated Central Hospital of Huzhou University","place":["Huzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Deqing People's Hospital","place":["Huzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Affiliated Central Hospital of Huzhou University","place":["Huzhou, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2010.11.009","article-title":"Insulin allergy","volume":"29","author":"Ghazavi","year":"2011","journal-title":"Clin Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1226231","article-title":"Case report: insulin hypersensitivity in youth with type 1 diabetes","volume":"14","author":"Alkhatib","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pop.2007.07.005","article-title":"Insulin pump therapy (Continuous subcutaneous insulin infusion)","volume":"34","author":"White","year":"2007","journal-title":"Prim Care"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.714","article-title":"Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues","volume":"23","author":"Radermecker","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2012.10.002","article-title":"Continuous subcutaneous insulin infusion allows tolerance induction and diabetes treatment in a type 1 diabetic child with insulin allergy","volume":"39","author":"Hasselmann","year":"2013","journal-title":"Diabetes Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2008.00348.x","article-title":"Insulin allergy desensitization with simultaneous intravenous insulin and continuous subcutaneous insulin infusion","volume":"9","author":"Neville","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s1081-1206(10)62554-9","article-title":"Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child","volume":"85","author":"Eapen","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.3.634-a","article-title":"Continuous subcutaneous insulin infusion to resolve an allergy to human insulin","volume":"25","author":"N\u00e4f","year":"2002","journal-title":"Diabetes Care"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2961","article-title":"Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin","volume":"26","author":"Sola-Gazagnes","year":"2003","journal-title":"Diabetes Care"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1186\/1476-7961-3-16","article-title":"Insulin allergy and resistance successfully treated by desensitisation with aspart insulin","volume":"3","author":"Matheu","year":"2005","journal-title":"Clin Mol Allergy"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.4158\/ep10183.Cr","article-title":"Failure of multiple therapies in the treatment of a type 1 diabetic patient with insulin allergy: A case report","volume":"17","author":"Koroscil","year":"2011","journal-title":"Endocr Pract"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-6-263","article-title":"Successful management of allergy to the insulin excipient metacresol in a child with type 1 diabetes: A case report","volume":"6","author":"Wheeler","year":"2012","journal-title":"J Med Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/394754","article-title":"Successful management of insulin allergy and autoimmune polyendocrine syndrome type 4 with desensitization therapy and glucocorticoid treatment: A case report and review of the literature","volume":"2014","author":"Rojas","year":"2014","journal-title":"Case Rep Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2021.05.004","article-title":"Rapid desensitization for insulin allergy in type 1 diabetes using an insulin pump: A case report and literature review","volume":"7","author":"Tian","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i20.7163","article-title":"Nursing a patient with latent autoimmune diabetes in adults with insulin-related lipodystrophy, allergy, and exogenous insulin autoimmune syndrome: A case report","volume":"10","author":"He","year":"2022","journal-title":"World J Clin cases"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00454-2.x","article-title":"Localized insulin allergy treated with continuous subcutaneous insulin","volume":"18","author":"Pratt","year":"2001","journal-title":"Diabetes Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.11.1.97b","article-title":"CSII in management of insulin allergy","volume":"11","author":"Valentini","year":"1988","journal-title":"Diabetes Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01567.x","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.04.027","article-title":"Severe insulin allergy successfully treated with continuous subcutaneous insulin infusion","volume":"97","author":"Fujikawa","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.02.016","article-title":"Successful desensitization by glargine administration in a patient with insulin allergy: A case report","volume":"84","author":"Hara","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.2.411","article-title":"Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes","volume":"24","author":"Moriyama","year":"2001","journal-title":"Diabetes Care"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1715012\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T07:35:21Z","timestamp":1771918521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1715012\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":21,"alternative-id":["10.3389\/fendo.2026.1715012"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1715012","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"article-number":"1715012"}}